Improved characterization of FSHD mutations

被引:20
作者
Zhang, YZ
Forner, J
Fournet, S
Jeanpierre, M
机构
[1] Ruijin Hosp, Shanghai, Peoples R China
[2] ICGM, Paris, France
[3] Cochin Hosp, Paris, France
来源
ANNALES DE GENETIQUE | 2001年 / 44卷 / 02期
关键词
facioscapulohumeral muscular dystrophy; FSHD; allele sizing;
D O I
10.1016/S0003-3995(01)01075-9
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Facioscapulohumeral muscular dystrophy (FSHD) is caused by the shortest alleles of the 3.3kb-tandem repeat array D4Z4 at 4q35. Molecular diagnosis of FSHD depends upon the separation of unusually large alleles by pulse-field electrophoresis after EcoRI and ECORI/BlnI. digestion. The exact number of alleles could not however be directly inferred from the size of DNA fragments owing to polymorphisms in the telomeric region of the locus. Knowing the exact repeat number of disease causing alleles may benefit genetic counselling, help to understand the mechanism of this singular disease and the population dynamics of subtelomeric sequences variations. We present here a partial digestion mapping method giving the exact number of repeats for disease causing alleles, and we suggest that most inaccuracies induced by common polymorphisms could be reduced by using EcoRV in place of ECoRI. After studying more than 300 DNA samples with both the standard method and this new method, we show that alleles size can be evaluated with a precision of less than one half repeat, and that the variations in length of the truncated repeat in the telomeric region of the D4Z4 locus can be evaluated. The results suggest that at least one intact chromosome 4 type repeat at 4q35 is needed to cause FSHD. (C) 2001 Editions scientifiques et medicales Elsevier SAS.
引用
收藏
页码:105 / 110
页数:6
相关论文
共 14 条
[1]  
BAKKER E, 1995, MUSCLE NERVE, pS39
[2]   Sequence homology between 4qter and 10qter loci facilitates the instability of subtelomeric KpnI repeat units implicated in facioscapulohumeral muscular dystrophy [J].
Cacurri, S ;
Piazzo, N ;
Deidda, G ;
Vigneti, E ;
Galluzzi, G ;
Colantoni, L ;
Merico, B ;
Ricci, E ;
Felicetti, L .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 63 (01) :181-190
[3]   Direct detection of 4q35 rearrangements implicated in facioscapulohumeral muscular dystrophy (FSHD) [J].
Deidda, G ;
Cacurri, S ;
Piazzo, N ;
Felicetti, L .
JOURNAL OF MEDICAL GENETICS, 1996, 33 (05) :361-365
[4]   ANALYSIS OF THE TANDEM REPEAT LOCUS D4Z4 ASSOCIATED WITH FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY [J].
HEWITT, JE ;
LYLE, R ;
CLARK, LN ;
VALLELEY, EM ;
WRIGHT, TJ ;
WIJMENGA, C ;
VANDEUTEKOM, JCT ;
FRANCIS, F ;
SHARPE, PT ;
HOFKER, M ;
FRANTS, RR ;
WILLIAMSON, R .
HUMAN MOLECULAR GENETICS, 1994, 3 (08) :1287-1295
[5]   Inter- and intrachromosomal sub-telomeric rearrangements on 4q35: implications for facioscapulohumeral muscular dystrophy (FSHD) aetiology and diagnosis [J].
Lemmers, RJLF ;
van der Maarel, SM ;
van Deutekom, JCT ;
van der Wielen, MJR ;
Deidda, G ;
Dauwerse, HG ;
Hewitt, J ;
Hofker, M ;
Bakker, E ;
Padberg, GW ;
Frants, RR .
HUMAN MOLECULAR GENETICS, 1998, 7 (08) :1207-1214
[6]   CORRELATION BETWEEN FRAGMENT SIZE AT D4F104S1 AND AGE AT ONSET OR AT WHEELCHAIR USE, WITH A POSSIBLE GENERATIONAL-EFFECT, ACCOUNTS FOR MUCH PHENOTYPIC VARIATION IN 4Q35-FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY (FSHD) [J].
LUNT, PW ;
JARDINE, PE ;
KOCH, MC ;
MAYNARD, J ;
OSBORN, M ;
WILLIAMS, M ;
HARPER, PS ;
UPADHYAYA, M .
HUMAN MOLECULAR GENETICS, 1995, 4 (05) :951-958
[7]  
LUNT PW, 1995, MUSCLE NERVE, pS103
[8]   Definitive molecular diagnosis of facioscapulohumeral dystrophy [J].
Orrell, RW ;
Tawil, R ;
Forrester, J ;
Kissel, JT ;
Mendell, JR ;
Figlewicz, DA .
NEUROLOGY, 1999, 52 (09) :1822-1826
[9]   Evidence for anticipation and association of deletion size with severity in facioscapulohumeral muscular dystrophy [J].
Tawil, R ;
Forrester, J ;
Griggs, RC ;
Mendell, J ;
Kissel, J ;
McDermott, M ;
King, W ;
Weiffenbach, B ;
Figlewicz, D ;
Cos, L ;
Langsam, A ;
Pandya, S ;
Martens, B ;
Brower, C ;
Herr, B ;
Downing, K ;
Gorell, WC .
ANNALS OF NEUROLOGY, 1996, 39 (06) :744-748
[10]   A prospective, quantitative study of the natural history of facioscapulohumeral muscular dystrophy (FSHD): Implications for therapeutic trials [J].
Tawil, R ;
Griggs, RC ;
McDermott, MP ;
Cos, L ;
Personius, KE ;
Langsam, A ;
Pandya, S ;
Maronian, A ;
Sass, A ;
McCoy, K ;
Brower, CA ;
Plumb, S ;
Martens, W ;
Herr, BE ;
Forrester, J ;
Figlewicz, D ;
Mendell, JR ;
Kissel, J ;
Rainey, F ;
Downing, K ;
King, WM .
NEUROLOGY, 1997, 48 (01) :38-46